Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of 0.28% sodium hyaluronate eye drops in moderate to severe dry eye
TCTR20250211004Phase 3Completed
- Sponsor
- Thailand Center of Excellence for Life Sciences
- Start
- Sep 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of sodium hyaluronate in dry eye syndrome (DED), sponsored by Thailand Center of Excellence for Life Sciences. Started Sep 2024; status: completed.
02
Drugs
sodium hyaluronate
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on TCTR20250211004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250211004.